LRRK2 contributes to monocyte dysregulation in Parkinson’s disease

Overview of attention for article published in Acta Neuropathologica Communications, November 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 64 Mendeley
citeulike: 1 CiteULike

Summary X Dimensions citations

So far, Dimensions has found 32 publications that cite this research output.

32

The most recent citing publications are shown below. View all 32 publications that cite this research output on Dimensions.

Indoleamine 2,3-dioxygenase (IDO1) – Can dendritic cells and monocytes expressing this moonlight enzyme change the phase of Parkinson’s Disease?

Article in International Immunopharmacology (April 2024)

Infiltrating Peripheral Monocyte TREM-1 Mediates Dopaminergic Neuron Injury in Substantia Nigra of Parkinson's Disease Model Mice

Preprint in Research Square (April 2024)

The R1441C-LRRK2 mutation induces myeloid immune cell exhaustion in an age- and sex-dependent manner

Preprint in bioRxiv (October 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.